The use of PET-18FDG imaging in the clinical evaluation of head and neck lymphoma

Clinical Oncology

Volumn 8, Issue 1, 1996, Pages 51-54

  Walsh, R M ^a,b   Wong, W L ^a,b   Chevretton, E B ^a,b   Beaney, R P ^b  

^a GUY S HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Lymphoma; Positron emission tomography

Indexed keywords

DEOXYGLUCOSE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUORINE; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEAD AND NECK TUMOR; HUMAN; HYPERPLASIA; LYMPH NODE; MALE; METABOLISM; MIDDLE AGED; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY; SCINTISCANNING; T CELL LYMPHOMA; CANCER DIAGNOSIS; CANCER LOCALIZATION; CLINICAL TRIAL; HEAD AND NECK CANCER; INTRAVENOUS DRUG ADMINISTRATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; AGED; DEOXYGLUCOSE; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; HYPERPLASIA; LYMPH NODES; LYMPHOMA, B-CELL; LYMPHOMA, HIGH-GRADE; LYMPHOMA, NON-HODGKIN; LYMPHOMA, T-CELL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0029692917     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0936-6555(05)80040-8     Document Type: Article

References (11)

1. Phelps MS. Emission computed tomography. Semink Nucl Med 1977;7:337-65.
2. Haberkorn U, Strauss LG, Reisser C, et al. Glucose uptake, perfusion and cell proliferation in head and neck tumours: Relation of positron emission tomography to flow cytometry. J Nucl Med 1991;32:1548-55.
3. Strauss LG, Conti PS. The application of PET in clinical oncology. J Nucl Med 1991;32:623-48.
4. Hoh CK, Hawkins RA, Glaspy JA, et al. Cancer detection with whole-body PET using 2-[18F] fluoro-2-deoxy-D-glucose. J Comput Assist Tomogr 1993;17:582-9.
5. Paul R. Comparison of fluorine-18-2-fluorodeoxyglucose and gallium-67 citrate imaging for detection of lymphoma. J Nucl Med 1987;28:288-92.
6. Leskinen-Kallio S, Ruotsalainen U, Nagren K, et al. Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: A PET study. J Nucl Med 1991;32:1211-18.
7. Newman JS, Francis IR, Kaminski MS, et al. Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose:-Correlation with CT. Radiology 1994;190:111-6.
8. Okada J, Yoshikawa K, Imazeki K, et al. The use of FDG-PET in the detection and management of malignant lymphoma: Correlation of uptake with prognosis. J Nucl Med 1991;32:686-91.
9. Okada J, Yoshikawa K, Itami M, et al. Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: A comparison with proliferative activity. J Nucl Med 1992;33:325-9.
10. Lindholm P, Minn H, Leskinen-Kallio S, et al. Influence of blood glucose concentration on FDG uptake in cancer: A PET study. J Nucl Med 1993;34:1-6.
11. Wong W, Chevretton E, McGurk M, et al. PET-FDG imaging in the clinical evaluation of head and neck cancer. J R Soc Med (in press).